Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q2 FY26 results · Jul–Sep 2025
Neuland Laboratories reported revenue from operations of ₹514.27 crore (up 65.4% from Q2 FY25) and net profit of ₹96.85 crore (up 194.9% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 514.27 | 310.84 | +65.4% | 292.75 | +75.7% |
| Other income | 1.80 | 4.33 | −58.5% | 7.86 | −77.1% |
| Total income | 516.07 | 315.18 | +63.7% | 300.61 | +71.7% |
| Profit before tax | 129.44 | 49.42 | +161.9% | 17.57 | +636.7% |
| Net profit for the period | 96.85 | 32.84 | +194.9% | 13.90 | +596.8% |
| EPS, basic (₹) | 75.49 | 25.60 | +194.9% | 10.83 | +597.0% |
| Net margin (%) | 18.8 | 10.6 | 4.7 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 514.27 | 310.84 | +65.4% | 292.75 | +75.7% |
| Other income | 1.80 | 4.33 | −58.5% | 7.86 | −77.1% |
| Total income | 516.07 | 315.18 | +63.7% | 300.61 | +71.7% |
| Profit before tax | 129.04 | 48.54 | +165.9% | 17.38 | +642.6% |
| Net profit for the period | 96.46 | 31.96 | +201.8% | 13.71 | +603.7% |
| EPS, basic (₹) | 75.18 | 24.91 | +201.8% | 10.68 | +603.9% |
| Net margin (%) | 18.8 | 10.3 | 4.7 |
Consolidated
- Filed with BSE
- 07 Nov 2025, 17:24 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2025, 17:24 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE